Frazier Financial Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
Frazier Financial Advisors's RIGL Position: Q3 2026 in Review
Frazier Financial Advisors opened a new position in Rigel Pharmaceuticals (RIGL) in Q3 2026: 22 shares worth $1.06K. The stake represents ﹤0.01% of the portfolio and ranks #645 among its holdings. This is a return to the name: Frazier Financial Advisors previously reported a position in RIGL as recently as Q1 2026.
Frazier Financial Advisors first reported a position in RIGL in Q1 2026 and has held it in 2 quarters since. 170 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.
- Frazier Financial Advisors held 22 shares of Rigel Pharmaceuticals worth $1.06K as of Q3 2026.
- Rigel Pharmaceuticals was a new Frazier Financial Advisors position in Q3 2026.
- Rigel Pharmaceuticals made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q3 2026, its #645 holding.
- Frazier Financial Advisors first reported a position in Rigel Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 170 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.
Based on Frazier Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.